Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1983
Characterization of a leukotriene D4 receptor in guinea pig lungS S Pong, R N DeHavenThe Journal of Allergy and Clinical Immunology|September 1, 1984
Lung tissue receptors for sulfidopeptide leukotrienesF A Kuehl, R N DeHaven, S S PongThe Journal of Biological Chemistry|August 25, 1983
Leukotriene C4 binding to rat lung membranesS S Pong, R N DeHaven, F A Kuehl, et al.Brain Research|October 31, 1975
Further evidence for cholinergic habenulo-interpeduncular neurons: pharmacologic and functional characteristicsM J Kuhar, R N DeHaven, H I Yamamura, et al.Molecular Pharmacology|February 1, 1990
Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactionsR R Huang, R N Dehaven, A H Cheung, et al.The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene familyS Zhang, Y Tong, M Tian, et al.Journal of Medicinal Chemistry|July 14, 2000
[Pro(3)]Dyn A(1-11)-NH(2): a dynorphin analogue with high selectivity for the kappa opioid receptorG Schlechtingen, L Zhang, A Maycock, et al.FEBS Letters|December 16, 1998
Endomorphins fully activate a cloned human mu opioid receptorJ Gong, J A Strong, S Zhang, et al.The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivityD L DeHaven-Hudkins, L C Burgos, J A Cassel, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2000
Arylacetamides as peripherally restricted kappa opioid receptor agonistsV Kumar, M A Marella, L Cortes-Burgos, et al.Pageof 1